Form 4 Filing for Cardiff Oncology, Inc. - PACE GARY W

Gary W. Pace, a director at Cardiff Oncology, Inc. (CRDF), reported a transaction on July 14, 2026. He acquired 687,285 shares of Common Stock through the exercise of a Common Stock Purchase Warrant. The exercise price was $0.00, and the reported market price was $1.455 per share. Following this transaction, Mr. Pace directly owns 2,043,661 shares of Common Stock. The warrant itself was acquired on the same date, with an exercise price of $1.33, and is exercisable after a six-month period or the Authorized Share Increase Date, with a term of five and a half years from the Initial Exercise Date. This filing is categorized as an OFFICER_DIRECTOR_CHANGE due to the nature of the reported transaction by a director.